APS - 69th Annual Meeting

How would you like your name to appear on your certificate?

Profession

What activities did you attend at the event?

Wednesday, March 9 - 12:30 am - 4:30 pm - Workshops

Thursday, March 10 - 7:00 am - 8:00 am - Early Career Roundtable

Thursday, March 10 - 8:00 am - 8:55 am - Invited Talk

Thursday, March 10 - 9:00 am - 10:15 am - Paper Sessions / Symposia

Thursday, March 10 - 10:30 am - 11:25 am - Invited Talk / Paper Sessions / Symposia

Thursday, March 10 - 11:30 am - 12:45 pm - Roundtables

Thursday, March 10 - 12:45 pm - 2:00 pm - Paper Sessions / Symposia

Thursday, March 10 - 2:15 pm - 3:30 pm - Invited Symposium / Paper Sessions / Symposia

Thursday, March 10 - 3:45 pm - 5:00 pm - Invited Talk

Friday, March 11 - 7:00 am - 8:00 am - Early Career Roundtable

Friday, March 11 - 8:00 am - 8:55 am - Invited Talk

Friday, March 11 - 9:00 am - 9:55 am - Invited Talk

Friday, March 11 - 10:15 am - 11:30 am - Invited Symposium / Paper Sessions / Symposia

Friday, March 11 - 11:30 am - 12:45 pm - Roundtables

Friday, March 11 - 1:00 pm - 2:15 pm - Paper Sessions / Symposia

Friday, March 11 - 2:30 pm - 3:45 pm - Invited Symposium / Paper Sessions / Symposia

Friday, March 11 - 4:00 pm - 5:15 pm - Invited Talk

Saturday, March 12 - 9:00 am - 9:55 am - Invited Talk / Paper Sessions

Saturday, March 12 - 10:15 am - 11:30 am - Awards Talk Series I

Saturday, March 12 - 11:30 am - 12:45 pm - Roundtables

Saturday, March 12 - 12:45 pm - 2:00 pm - Awards Talk Series II

Saturday, March 12 - 2:15 pm - 3:30 pm - Invited Symposium / Paper Sessions

Saturday, March 12 - 3:45 pm - 5:00 pm - Invited Talk / Paper Sessions / Symposia

Agreement

By completing this form, you attest that you have participated in all selected activities in thier entirety.

I agree

Please rate the following:

The program was relevant to my work.

Content matched stated objectives.

Usefulness of handouts/AV.

Quality of facilities.

How well did the educational sessions give a balanced view of therapeutic options, including the use of generic names?

If you rated any of the above questions with 'fair,' 'poor,' 'disagree,' or 'strongly disagree' please explain:

Please rate the speaker(s) as a group. You will have the opportunity to elaborate on an individual speaker in the following question.

Objective 1: Describe how psychosomatic medicine oriented basic science may be translated into the development and implementation of randomized controlled trials (RCTs) of interventions to improve health outcomes in chronic and life-limiting illness.

By meeting the above objective my professional competence will increase because I have acquired new strategies to use in my practice.

By meeting the above objective my professional performance will improve because I should be able to implement the new strategies.

By meeting the above objective my patient outcomes should improve due to the implementation of newly-learned strategies.

If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:

Objective 2: Identify how psychosomatic medicine oriented basic science and resulting RCTs may be translated into the care and management of patients in clinical and community practice.

By meeting the above objective my professional competence will increase because I have acquired new strategies to use in my practice.

By meeting the above objective my professional performance will improve because I should be able to implement the new strategies.

By meeting the above objective my patient outcomes should improve due to the implementation of newly-learned strategies.

Objective 3: Describe the biological mechanisms by which psychosocial and behavioral interventions may improve clinical health outcomes in major chronic and life-limiting illnesses.

By meeting the above objective my professional competence will increase because I have acquired new strategies to use in my practice.

By meeting the above objective my professional performance will improve because I should be able to implement the new strategies.

By meeting the above objective my patient outcomes should improve due to the implementation of newly-learned strategies.

Discuss the principles, methods, and applications of widely used laboratory bench techniques.

Explain how to disseminate and implement evidence-based behavioral interventions in the community.

Identify the study designs, methods and analytic techniques appropriate for use in the development and early testing of behavioral interventions.

Discuss the importance of seeking research funding early in one’s career.

Define the role and potential of interactive media in psychosomatic medicine.

Differentiate the quality of interactive media programs in psychosomatic medicine.

List underlying mechanisms for health-related behavior change.

Discuss whether reductions in cardiac vagal control were observed during physiologically-assessed menopausal hot flashes in the ambulatory setting.

Discuss whether measures of psychosocial stress, as assessed by ecological momentary assessment methods, are related to progression of subclinical cardiovascular disease.

Discuss whether or not cumulative exposures to traumatic psychological stress are associated with elevated inflammatory activity in patients with cardiovascular disease.

Describe how interactions of psychosocial and biological processes at the population level complements research involving targeted samples and experimental manipulations.

Discuss new research on psychosomatic contributions to and mechanisms of telomere shortening and cellular aging.

Describe the implications of this work in informing interventions designed to prevent accelerated cellular aging.

Discuss whether acute coronary syndrome (ACS) patients with current PTSD symptoms during hospitalization differ from patients without current PTSD symptoms on perceived risk of ACS recurrence.

Describe how early hydrocortisone treatment can buffer the subsequent development of PTSD symptoms in trauma victims.

Discuss whether post-traumatic stress disorder is related to incident coronary heart disease in a prospective study.

Summarize the current state of sleep science and suggest promising avenues for translational research.

Explain the influence of Type-D personality on all-cause mortality in a large sample of German cardiac patients.

Discuss measurement equivalence, validity and sensitivity of the Type D scale in patients with ischemic heart disease in 16 European and 4 English-speaking countries.

Describe how Type D personality (the combination of negative affectivity and social inhibition) is associated with CVD risk factor profiles in the general Icelandic population, with a specific focus on gender differences.

Discuss a contemporary look at research and intervention with pregnant and non-pregnant African American women of reproductive age.

Discuss whether there is evidence from indirect comparisons of randomized clinical trials on the prophylaxis of migraine that some placebos are more effective than others.

Discuss whether a placebo intervention has an impact on the diameter of coronary arteries.

Explain the effects of video review of baseline performance on outcome ratings in a placebo surgery trial.

Discuss the principles of behavioral therapies for sleep as well as basic assessment tools in sleep medicine.

Examine models for dissemination and implementation of health management interventions.

Discuss whether negative mood induced by forced withdrawal from habitual physical exercise is associated with inflammatory responses to mental stress.

Define the buffering role of social support on the association between anger and IL-6 reactivity in response to acute stress.

Explain how establishing infection history can be an additional determinant of stress responses.

Assess whether improvement in somatic or cognitive depressive symptoms was related to an improved cardiac outcome and whether this association was different for patients receiving usual care or cognitive behavior therapy.

Evaluate the utility of four depressive symptom clusters i.e., depressed affect, positive affect, somatic symptoms, and interpersonal distress in predicting 5-year incidence of coronary artery calcification.

Discuss the relationship among somatic and cognitive symptoms of depression and various pro-inflammatory markers in Heart Failure patients.

Examine the effects of a Mindfulness-Based Stress Reduction (MBSR) intervention on psychophysiological responses during a laboratory stress protocol.

Explain how specific facets of mindfulness are related to health.

Describe the results of a small randomized controlled trial of MBSR treatment on psychological, psychophysiological, endocrine, and immune outcomes among Parkinson's Disease patient-partner dyads.

Examine Hispanic/Latino health outcomes and explore mechanisms of risk and resilience.

List the most promising targets of intervention: stress, depression, and Type D personality in determining whether treatment of psychosocial risk factors can improve medical outcomes in patients with established heart disease.

Discuss youth compliance in reporting time of awakening.

Discuss the association of attachment style, cortisol awakening response (CAR), and cortisol profile across the day in healthy adults.

Link intensity and duration of different types of emotions expressed during a psychosocial stressor to variations in strength of cortisol stress responses and furthermore, to differentiate those associations from links between self-reported emotions and cortisol stress responses.

Examine gender differences regarding the explanatory role of education, health behaviors, and social support in the association of depressive mood with premature mortality.

Discuss potential sex differences in the relationship between mood disorders and CRP, an inflammatory marker

Discuss the comorbidity between anxiety disorders (panic disorder, social phobia) and four neuropsychiatric disorders (migraine, epilepsy, fibromyalgia, chronic fatigue syndrome).

Describe core concepts and basic techniques of Motivational Interviewing(MI).

Summarize evidence supporting use of MI across multiple domains of healthcare including pediatric obesity, alcoholism, and cross-cultural training of physicians.

Discuss the promise of MI for the healthcare system of the future.

Review some of the spectacular successes, as well as impressive failures and difficult missteps of the Cardiovascular field.

Identify the right dose before embarking on a trial.

List the ways a risk marker may not be causal.

Discuss early career transitions for students about to enter the job market as well as early career professionals encountering decisions about their career trajectory.

Examine the stress-reduction pathways in mindful awareness and mindfulness interventions, using neuroimaging and biological assessment methods.

Utilize stress management intervention as a probe to illuminate biobehavioral processes that mediate stress-health associations in persons with medical illnesses.

Discuss the epidemiological association between depression and type 2 diabete.

Discuss the role of the hypothalamic-pituitary-adrenal axis in the pathophysiology of obesity and type 2 diabetes.

Discuss evidence supporting neuroendocrine dysregulation in type 2 diabetes.

Evaluate the impact of acute stress and relationship-focused imagery on cardiac vagal control.

Discuss the validity of High-Frequency Heart Rate Variability (HF-HRV) during Marital Conflict.

Define the potential role of alexithymia in cardiovascular emotional dampening.

Discuss cutting edge psychosomatic research in asthma.

Discuss the breadth of Dr. Baum’s influence on the field of psychosomatic medicine.

Discuss mental health problems related to pregnancy and postpartum period, in particular PTSD and FoC.

Discuss NIH policies and funding opportunities in psychosomatic medicine research.

List candidate biological mechanisms that convert early psychosocial risks into life-long disease vulnerabilities.

Discuss a range of early psychosocial risks, including low childhood socioeconomic status, childhood abuse, post traumatic stress syndrome, and early separation from parents.

Identify promising directions for future research with potential application to prevention and intervention.

Discuss the effects of social context, in the form of social-evaluative threat (SET), and individual differences in control attributions.

Define the role of perceived social support in predicting subjective and objective health outcomes in heart failure patients.

Examine the effects of momentary experiences of evaluative threat on ambulatory blood pressure.

Discuss whether psychological factors predict physiological outcomes in hematopoietic stem cell transplant (HSCT) patients, including time to neutrophil recovery and cytokine levels.

Discuss whether psychosocial factors and cortisol slope predicted survival in patients with metastatic renal cell carcinoma (mRCC) and to determine possible activation of pro-inflammatory transcription control pathways.

Describe the relationships between social support, circadian rhythms, endocrine activation and immune function among women newly diagnosed with breast cancer.

Describe the effects of yoga on buffering changes in QOL and cortisol slope in women with breast cancer undergoing radiotherapy.

Discuss the effects of anger awareness and expression training, relaxation, and a no-treatment control on people with chronic headaches.

Explain cognitive behavioural therapy for adjusting to Multiple Sclerosis - does it work and for whom does it work best?

Discuss empirically-based research on the efficacy of Integrative Medicine approaches, particularly mind-body and touch therapies, on immunity and patient-centered outcomes in older adults and individuals with cancer.

Explain the impact of emotional distress on quality of life and disease progression in this clinical condition.

Illustrate the effects of antidepressants on autonomic nervous system functioning.

Describe how inflammation markers are associated with psychopathology indicators and antidepressant treatment in a large psychiatric sample.

Explain the impact of an enhanced depression care intervention on adherence to risk reducing behaviors.

Examine the extent to which negative mood moderates effects of acute stress on taste perception and appetite.

Identify mechanisms through which stress and weight changes may contribute to craving and smoking relapse.

Define the mediating role of leptin in the obesity-inflammation link pre-to-post behavioral interventions among individuals with elevated blood pressure.

Explain how theories and investigations of risk and protective factors for adjustment to chronic disease and randomized, controlled intervention trials can reciprocally inform each other.

Cite promising, evidence-based candidates for psychosocial mechanisms for the efficacy of recent randomized, controlled trials.

Discuss directions for theory, research, and practice.

Discuss the use of PROMIS instruments.

Discuss potential links between depression, cardiovascular events and survival in a cohort of 271 newly diagnosed ovarian cancer patients.

Describe the association between pretreatment psychosocial factors (social support and distress) and the quality of life benefits derived from a brief cognitive-behavioral stress management program.

Discuss the association between repeated experience of depressive symptoms and subsequent WBC levels in patients with coronary heart disease (CHD).

Describe the association between depressive symptoms and inflammatory gene polymorphisms among patients with end stage renal disease.

Discuss the relationship between depressive and grief symptoms with IL-6 at the baseline of a randomized clinical trial for Complicated Grief.

Discuss the association between asthma, chronic obstructive pulmonary disease and mental health in China.

Compare the differences in heart rate variability between anxious and non-anxious COPD patients to healthy controls.

Define the role of patient and caregiver catastrophizing on patient depressive symptoms in the context of organ transplantation.

Review research linking aspects of the social environment to genetic, neural, and neuroendocrine processes that are prognostic for health.

Describe patterns of central brain function related to peripheral biological systems that play a role in physical health and illness.

Discuss the recent emergence of rigorous neuroscientific research on the impact of contemplative practice on the brain and behavior.

Describe patterns of central brain function related to peripheral biological systems that play a role in physical health and illness.

Explain how to foster links between the American Psychosomatic Society (APS) and the Society for Psychophysiological Research (SPR).

Discuss whether individual differences in sensitivity to one kind of pain relate to individual differences in sensitivity to the other.

Review whether factors that up- or down-regulate one type of pain affect the other in a similar manner.

Cite both the opportunities and challenges inherent in developing behavioral interventions.

Discuss the associations between actigraphy-assessed sleep characteristics and 24-hour ambulatory blood pressure in a sample of Black and White adolescents.

Describe the effect of sleep loss and trait emotionality (neuroticism) on cardiovascular adaption to stress.

Explain the relationship between sleep and negative symptomatology in heart failure.

Evaluate a model in which early life experiences are predicted to relate to menarcheal age which is, in turn, predicted to relate to CVD risk.

Describe the effects of psychosocial and socio-economic factors on immunity and aging.

Examine whether child emotional functioning mediated the association between child socioeconomic status and adult inflammation, or whether the relationship between child emotional functioning and adult inflammation was modified by child socioeconomic status.

Examine if threat and challenge appraisals of a standardized acute stressor are associated with leukocyte telomere length in a sample of postmenopausal women.

Discuss the feasibility of a new technology, the AutoSense, to assess stress response in the natural environment.

Describe the effects of hemoconcentration on coagulation activity during acute psychological stress.

Describe how basic behavioral research on stress, neurobiology and appetitive drive can lead to the development of novel interventional approaches to obesity.

Discuss prospective relationships among sleep and health outcomes, including response to interventions.

Discuss putative mechanisms linking sleep to health outcomes.

Discuss opportunities to intervene on sleep and improve health.

Explain how main effects, mechanisms, and moderators of randomized, controlled interventions can enhance quality of life and health in women diagnosed with breast cancer.

Describe relationships between catastrophizing changes and outcome changes in an RCT for chronic pain.

Discuss further evidence for a disturbed functional anatomy in the neural underpinnings of emotional regulation and interoception in somatoform pain disorder.

Compare biological and psychological correlates of differences in pain sensitivity under controlled laboratory conditions in women with and without abuse histories.

Objective 4: Explain the psychological, social, behavioral, and functional mechanisms by which psychosocial interventions may improve physical health outcomes in chronic or life-limiting illnesses.

By meeting the above objective my professional competence will increase because I have acquired new strategies to use in my practice.

By meeting the above objective my professional performance will improve because I should be able to implement the new strategies.

By meeting the above objective my patient outcomes should improve due to the implementation of newly-learned strategies.

Please answer the following:

Do you believe this activity was appropriate for the scope of your professional activities?

Was the educational content scientifically sound?

Was the educational content free of commercial bias?

Was the mode of education effective to learning?

If faculty spoke about off-label or investigational uses of a product, was that information disclosed to you?

If you answered "No" to any of the above questions, please explain.

Were you solicited by sales personnel in an educational room while you attended this educational activity?

If you answered "Yes" to the above question, please explain.

What did you learn during this activity that you intend to integrate into your practice?

What questions have arisen in your practice for which you need answers/strategies that you can implement?

What patient problems or patient challenges do you feel you are not able to address appropriately or to your satisfaction?

What problems are your patients communicating to you that need attention or follow up?

Are you interested in basic, intermediate or advanced level trainings?

What barriers might you have that would interfere with implementation of new information learned from this training?

How can this training (the overall meeting) be improved to better impact competence, performance and/or patient outcomes?

Additional comments: